A shadow market for unapproved slimming drugs is propelled by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.
Investigational Treatment Acquiring Traction Online
The experimental drug, which is still in clinical trials, is being promoted by online personalities for its alleged fat-burning effects. Viewers are encouraged to contact these profiles privately for source information, while also receiving discount codes.
Active Commerce on Messaging Platforms
Additionally, a flourishing market exists on messaging services, where groups with thousands of members share “before and after” photos, injection guides and assertions of rapid UK delivery. Sellers market the drug there before redirecting buyers to WhatsApp for purchases.
Learning About Retatrutide
Retatrutide is an investigational injectable developed by US drugmaker Eli Lilly. The drug affects three gut hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies suggest it could assist patients reduce up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted digitally as the next Ozempic.
Medical Experts Express Concerns
However, doctors and pharmacists have warned that the sale of what is still an unlicensed medication in the UK is worrisome and could lead to individuals injecting substances of unknown origin.
Some professionals said the demand for the experimental drug could be linked to the increasing price of approved weight loss products such as Mounjaro.
Legal Position and Enforcement
Selling the unapproved drug on social media or messaging apps is prohibited in the UK, as it is an unapproved medication that cannot be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.
Several content creators try to sidestep the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but promotion and supply can still breach pharmaceutical, advertising, and customer laws, potentially leading to fines, prosecution or imprisonment.
Platform Response and Content Removal
Based on TikTok, the platform has removed violative material and banned related keywords and search suggestions. The company said it was dedicated to maintaining the service safe and allocating resources in strengthening compliance measures.
Digital Trading Operations
Investigations also found communities with up to 9,000 members marketing retatrutide using Telegram's integrated discovery tool, which functions like a online catalog. Typing “retatrutide” instantly displays groups with numerous of members, filled with images of weight loss, glowing testimonials and detailed instructions for preparing or administering at home.
Within minutes of joining one community, a seller posted WhatsApp details, where most purchases take place. The vendor sent an instruction manual and guaranteed delivery within two days. When questioned whether the substance was authentic, one seller responded: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. None asked about weight, medical conditions or previous experience.
Product Details and Pricing
Inside these groups, posts display black plastic packages with postal service labels, stating to contain new batches. One communication stated: “It took eight of us to load them this morning.”
Buyers can select between powder vials, mixed at residence with sterile water, or pre-filled injectors usually priced at £160 for 20 milligrams. When questioned how long a injector should last, sellers give conflicting answers varying between a several days to “depends on your body”.
Platform Moderation and Safety Actions
A representative for the messaging service stated it actively monitored harmful material on its service including content that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Cautions
“Individuals are injecting substances they cannot confirm. Even if the science behind retatrutide is valid, these online products may not include what they claim,” said Jason Murphy, the head of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of an online medical service connected the increase in interest to current price rises for approved slimming medications such as Mounjaro. “With costs rising, individuals are turning to social media. But counterfeit treatments are extremely risky. You cannot know what’s inside or whether the environment they were made in was sterile,” she explained.
Her staff has already seen individuals harmed by personal administration from unverified suppliers. “We understand the frustration, but purchasing from Telegram or communication platforms is gambling with your well-being,” said Wyllie. “These materials could be contaminated or improperly measured.”
Producer Statement
A representative from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been reviewed or approved by any government authority anywhere in the world. “Consequently at this point no one can sell [it] for human use,” they said, noting that any product “falsely representing itself as a company experimental substance not yet approved … may subject patients to possibly serious health risks”.
